NewGenIvf Group (NASDAQ:NIVF) Major Shareholder Financial Lp Hrt Purchases 137,541 Shares

NewGenIvf Group Limited (NASDAQ:NIVF) major shareholder Financial Lp Hrt acquired 137,541 shares of the business’s stock in a transaction dated Friday, May 22nd. The shares were bought at an average price of $0.99 per share, for a total transaction of $136,165.59. Following the completion of the acquisition, the insider owned 111,885 shares in the company, valued at approximately $110,766.15. This trade represents a -536.10% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Financial Lp Hrt also recently made the following trade(s):

• On Tuesday, May 26th, Financial Lp Hrt purchased 27,993 shares of NewGenIvf Group stock. The stock was acquired at an average price of $0.92 per share, for a total transaction of $25,753.56.

NewGenIvf Group Trading Up 8.3%

NASDAQ NIVF opened at $0.85 on Thursday. NewGenIvf Group Limited has a one year low of $0.72 and a one year high of $1,839.00. The company’s 50 day moving average price is $1.68 and its 200 day moving average price is $6.93. The company has a debt-to-equity ratio of 0.16, a quick ratio of 2.98 and a current ratio of 3.12.

NewGenIvf Group (NASDAQ:NIVF) last posted its quarterly earnings results on Tuesday, March 31st. The company reported ($287.24) EPS for the quarter. The company had revenue of $1.42 million for the quarter. As a group, equities research analysts forecast that NewGenIvf Group Limited will post 4.74 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d)” rating on shares of NewGenIvf Group in a report on Monday, April 27th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, NewGenIvf Group presently has an average rating of “Sell”.

NewGenIvf Group Company Profile

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.